For the Inventor, By the Inventor

Enter assignee name

Glycozym Aps

Calculating rank

USPTO Granted Patents = 15

% Expired Patents = 73.3

Forward Citations = 59

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Henrik Clausen (15 out of 52 patents)

Tilo Schwientek (7 out of 7 patents)

Eric Bennett (6 out of 9 patents)

4. Rudi Steffensen (2 out of 3 patents)

5. Margarida Amado (2 out of 3 patents)

6. Helle Hassan (1 out of 1 patent)

7. Celso Albuquerque Reis (1 out of 1 patent)

8. Jochen Gätgens (1 out of 1 patent)

9. Detlef Eisenkrätzer (1 out of 1 patent)

10. Frau Helle Hassan (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 7476527 - [object Object] (2009-01-13),

2. 7449316 - UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1 (2008-11-11),

3. 7381554 - UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/N-acetylglucosamine-β1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2/4GnT (2008-06-03),

4. 7374919 - UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2 (2008-05-20),

5. 7338932 - Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments (2008-03-04),

6. 7332279 - [object Object] (2008-02-19),

7. 7115404 - UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1 (2006-10-03),

8. 7097994 - [object Object] (2006-08-29),

9. 7094887 - [object Object] (2006-08-22),

10. 7078206 - UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GalNAc) β1,6N-acetylglucosaminyltransferase, C2GnT3 (2006-07-18),

11. 6995004 - UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT (2006-02-07),

12. 6916649 - UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2 (2005-07-12),

13. 6794169 - UDP-N-acetylglucosamine: galactose-&bgr;1,3-N-acetylgalactosamine-&agr;-R / (GlcNAc to GalNAc) &bgr;1,6-N-acetylglucosaminyltransferase, C2GnT3 (2004-09-21),

14. 6635461 - UDP-N-acetylglucosamine: galactose-&bgr;1, 3-N-acetylgalactosamine-&agr;-R/(GlcNAc to GalNAc) &bgr;1,6-N-acetylglucosaminyltransferase, C2GnT3 (2003-10-21),

15. 6465220 - Glycosylation using GalNac-T4 transferase (2002-10-15),

Company Overview

Glycozym Aps is a biotechnology company based in Holte, Denmark, specializing in the development of innovative solutions for glycoscience. The organization focuses on creating advanced products and technologies that enhance the understanding and application of carbohydrates in various fields, including pharmaceuticals and diagnostics. Glycozym's expertise lies in enzymatic processes and the manipulation of glycan structures, contributing to advancements in therapeutic and diagnostic methodologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

15 Patents

#1 in Holte

#194 in Denmark

#39,991 in the World

Glycozym Aps

Forward Citations = 59

10 inventors:

Henrik Clausen (15 out of 52 patents)

Tilo Schwientek (7 out of 7 patents)

Eric Bennett (6 out of 9 patents)

4. Rudi Steffensen (2 out of 3 patents)

5. Margarida Amado (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glycozym Aps. Retrieved from https://idiyas.com/company/glycozym-aps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…